Open AccessAtherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria
Author(s) -
Cajetan C Onyedum,
Ekenechukwu Young,
Michael Iroezindu,
Chinwe Chukwuka,
UI Nwagha
Publication year - 2014
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.139217
Subject(s) - medicine , dyslipidemia , body mass index , triglyceride , gastroenterology , lipid profile , lipoprotein , high density lipoprotein , human immunodeficiency virus (hiv) , anthropometry , cholesterol , endocrinology , immunology , obesity
Metabolic abnormalities are often common among human immunodeficiency virus (HIV) patients. The atherogenic index of plasma (AIP) is increasingly being used as a screening tool for dyslipidemia as it predicts the presence of small, dense, and highly atherogenic low density lipoprotein (LDL) and high density lipoprotein (HDL) particles. The aim of this study was to identify the pattern and predictors of an abnormal atherogenic index in highly active antiretroviral therapy (HAART)-naïve HIV patients.